Use of Autoreactive Antibodies in Blood of Patients with Pancreatic Intraductal Papillary Mucinous Neoplasms (IPMN) for Grade Distinction and Detection of Malignancy.
Cancers (Basel)
; 14(15)2022 Jul 22.
Article
em En
| MEDLINE
| ID: mdl-35892825
ABSTRACT
(1)